CAS: 1859053-21-6; 8-Fluoro-5-(4-((Methylamino)Methyl)Phenyl)-2,3,4,6-Tetrahydro-1H-Azepino[5,4,3-Cd]Indol-1-One ((1S,4R)-7,7-Dimethyl-2-Oxobicyclo[2.2.1]Heptan-1-yl)Methanesulfonate

双环 [2.2.1] 乙烷-1-甲烷硫酸,7,7-二甲基-2-氧,(1S,4R)-,结合8-氟-1,3,4,5-四氢-2-[4-[甲基]苯]-6-H-pyrrolo[4,3,2-ef][2,benzazepin-6-one]-6H-pyrrolo[4,3,2-(甲基)甲基)-H-pyrolo]-6-H-pyrolo[3,2-(甲基)甲基)-H-pyrolo[3,2-ef][2,2,benzazepin-6-one]-py,代表一种具有特定结构和功能特征的复杂的有机化合物化合物.双环形结构表明碳原子的独特的安排有助于其化学稳定性和再活性.甲烷硫酸组的存在表明,甲烷硫磺酸组的酸性特性可能具有酸性,这可能会影响溶性与生物系统的溶性相互作用. 二甲基化合物的复杂结构和功能组的化学剂的进一步发展可能使其在特定化学体化学体中产生.

结构式图片

欧盟法规

C&L通报

合成工艺路线路线简述

    Methyl N-[[4-(6-Fluoro-3-Oxido-10-Aza-3-Azoniatricyclo[6.4.1.04,13]Trideca-1(13),5,7-Trien-10-yl)Phenyl]Methyl]-N-Methylcarbamate 以88的收率获得瑞卡帕布樟脑磺酸盐
    参考文献: Method Of Preparing Poly(Adp-Ribose) Polymerases Inhibitors[fr] Procede De Preparation D'Inhibiteurs De Poly(Adp-Ribose) Polymerases
    标题: Method Of Preparing Poly(Adp-Ribose) Polymerases Inhibitors[fr] Procede De Preparation D'Inhibiteurs De Poly(Adp-Ribose) Polymerases
    摘要:该发明涉及一种新的,汇聚的方法制备聚(Adp-核糖)聚合酶的小分子抑制剂,例如8-氟-2-{4-[(甲基氨基)甲基]苯基}-1,3,4,5-四氢-6H-氮杂[5,4,3-Cd]吲哚-6-酮,通过关键的sonogashira偶联反应和cul促进的吲哚形成.

    海关参考信息

    专利信息


    专利号:US-2022118094-A1
    优先权日:2019-02-21
    标题:Synthesis of biomimetic cell wall structure
    发明人:WANG YONG; SHI PENG
    权利人:PENN STATE RES FOUND
    摘要:The present invention relates generally to methods of generating a biomimetic cell wall (BCW) on a target surface, compositions comprising the BCW, and methods of use of the compositions, including biomedical applications of the BCW coated compositions.

    专利号:US-2023391824-A1
    优先权日:2021-02-08
    标题:Rationale, design, synthesis and validation of a small molecule anticancer agent
    发明人:JAIN MOHIT; NARENDRAN ARUMUGAVADIVEL
    权利人:NARENDRAN ARUMUGAVADIVEL
    摘要:LIN28 is an RNA binding protein that binds and inhibits the expression and maturation of Iet7 microRNA that carries key tumor suppressor functions. Thus, LIN28 is a feasible and effective molecular target for directed inhibition with the potential to provide therapeutic benefit to a diverse group of aggressive malignancies. The present disclosure relates generally to the Rationale, Design, Synthesis and Validation of a Novel Small Molecule Inhibitor of LIN28, coined Compound of formula (I), for the Treatment of Adult and Pediatric Malignancies. In addition, indications of this agent to block cancer metastasis, inhibit cancer stem cells to prevent relapse, and to synergize with immunotherapy, chemotherapy and radiotherapy are also been described.

    专利号:WO-2025023769-A1
    优先权日:2023-07-25
    标 题:Novel synthesis method of 18f-rucaparib
    发明人:CHEON CHEOL-HONG; PARK JINJAE; SEO JUAN
    权利人:UNIV KOREA RES & BUS FOUND
    摘要:The present invention relates to a method for efficiently preparing rucaparib for a PET image. More specifically, the present invention relates to an improved preparation method for synthesizing [18F]-rucaparib in excellent yield by means of a pathway for synthesizing a pinacol boronate derivative, which is a key intermediate, by using, as a starting material, a 2-iodoaniline derivative prepared by a novel synthesis method.

    专利号:WO-2025137620-A1
    优先权日:2023-12-21
    标题:Methods for high quality and high accuracy methylation sequencing
    发明人:KENNEDY ANDREW
    权利人:GUARDANT HEALTH INC
    摘要:Provided herein are methods and compositions for calibrating one or more base calling metrics in a sequencing by synthesis reaction, and for calling at least a portion of nucleobases in a converted region of a DNA molecule using the one or more calibrated base calling metrics. Provided herein are also methods for determining the likelihood that a subject has a disease or condition, such as cancer.

    专利号:EP-4288444-A1
    优先权日:2021-02-08
    标题:Rationale, design, synthesis and validation of a small molecule anticancer agent

    专利号:WO-2022165606-A1
    优先权日:2021-02-08
    标 题:Rationale, design, synthesis and validation of a small molecule anticancer agent
    北京迈索化学技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.huafenginfo.com
    企业联系电话:010-57862036,65405760👤
    📞北京迈索化学技术有限公司 ⚠️参考联系方式
    联系人:崔先生
    电话:010-57862036,65405760
    手机:13366977697
    传真:010-57862181
    邮箱:sales@mesochem.com
    通信地址: 北京市亦庄经济技术开发区荣华中路力宝广场9座23层
    邮编: 100176
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:北京市亦庄经济技术开发区荣华中路力宝广场9座23层
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    北京华奉联博科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.huafenginfo.com
    电话:010-57862036,65405760👤
    📞 北京华奉联博科技有限公司⚠️参考联系方式

    电话: 010-57862036,65405760
    邮件:sales@mesochem.com
    网址: http://www.huafenginfo.com
    地址:北京市亦庄经济技术开发区荣华中路力宝广场9座23层
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    北京市亦庄经济技术开发区荣华中路力宝广场9座23层
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Available from http://www.ncbi.nlm.nih.gov/books/NBK548767/ doi: 10.2147/TCRM.S149248. eCollection 2018. Review.
    3: Cosgrove CM, O'Malley DM. How safe is rucaparib in ovarian cancer? Expert Opin Drug Saf. 2018 Dec;17(12):1249-1255. doi: 10.1080/14740338.2018.1550067. Epub 2018 Dec 11. Review. doi: 10.2217/fon-2018-0215. Epub 2018 Aug 14. Review.
    5: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from http://www.ncbi.nlm.nih.gov/books/NBK500908/ doi: 10.1177/1758835918778483. eCollection 2018. Review.

    合成参考文献


    参考文献:10.1016/j.ejmech.2023.115925
    摘要:Zhang J, Zhao L, Wang Y. Synthesis and clinical application of small-molecule drugs approved to treat prostatic cancer. European Journal of Medicinal Chemistry. 2023 Dec;262():115925. doi: 10.1016/j.ejmech.2023.115925.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知